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Background: Proneural genes encode basic helix–loop–helix transcription factors that specify distinct neuronal
identities in different regions of the nervous system. In the embryonic telencephalon, the proneural genes Neurog1
and Neurog2 specify a dorsal regional identity and glutamatergic projection neuron phenotype in the presumptive
neocortex, but their roles in cell fate specification in the olfactory bulb, which is also partly derived from dorsal
telencephalic progenitors, have yet to be assessed. Given that olfactory bulb development is guided by interactions
with the olfactory epithelium in the periphery, where proneural genes are also expressed, we investigated the roles
of Neurog1 and Neurog2 in the coordinated development of these two olfactory structures.
Results: Neurog1/2 are co-expressed in olfactory bulb progenitors, while only Neurog1 is widely expressed in
progenitors for olfactory sensory neurons in the olfactory epithelium. Strikingly, only a remnant of an olfactory bulb
forms in Neurog1−/−;Neurog2−/− double mutants, while this structure is smaller but distinguishable in Neurog1−/−
single mutants and morphologically normal in Neurog2−/− single mutants. At the cellular level, fewer glutamatergic
mitral and juxtaglomerular cells differentiate in Neurog1−/−;Neurog2−/− double-mutant olfactory bulbs. Instead,
ectopic olfactory bulb interneurons are derived from dorsal telencephalic lineages in Neurog1−/−;Neurog2−/− double
mutants and to a lesser extent in Neurog2−/− single mutants. Conversely, cell fate specification is normal in Neurog1−/−
olfactory bulbs, but aberrant patterns of cell proliferation and neuronal migration are observed in Neurog1−/− single and
Neurog1−/−;Neurog2−/− double mutants, probably contributing to their altered morphologies. Finally, in Neurog1−/− and
Neurog1−/−;Neurog2−/− embryos, olfactory sensory neurons in the epithelium, which normally project to the olfactory bulb
to guide its morphogenesis, fail to innervate the olfactory bulb.
Conclusions: We have identified a cell autonomous role for Neurog1/2 in specifying the glutamatergic identity of
olfactory bulb neurons. Furthermore, Neurog1 (and not Neurog2) is required to guide olfactory sensory neuron innervation
of the olfactory bulb, the loss of which results in defects in olfactory bulb proliferation and tissue morphogenesis. We thus
conclude that Neurog1/2 together coordinate development of the olfactory system, which depends on tissue interactions
between the olfactory bulb and epithelium.
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innervationBackground
The olfactory system is the part of the central nervous
system that is responsible for detecting and processing
odors. In vertebrates, the olfactory system consists of
three major components: the olfactory epithelium (OE),
the olfactory bulb (OB), and the olfactory cortex. Odor
molecules are initially detected by olfactory sensory* Correspondence: cschuurm@ucalgary.ca
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reproduction in any medium, provided the orneurons (OSNs) in the OE, which project their axons to
the OB, where odor signals are refined and enhanced be-
fore being relayed to the piriform/olfactory cortex,
where signal processing and odor perception occurs.
The OB is a ventroanterior protrusion of the cerebrum
that serves as an intermediate processing center for ol-
factory signals. It is comprised of projection neurons
and interneurons, each with distinct embryonic origins.
Mitral and tufted cells are glutamatergic projection neu-
rons that arise from dorsal telencephalic (that is, pallial)
progenitors between embryonic day (E) 11 and E13 inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.neuraldevelopment.com/content/7/1/28mouse [1-3]. At E13.5, pallial progenitors also give rise
to glutamatergic juxtaglomerular cells, which function as
excitatory interneurons [1]. Later, at ~ E14.5, inhibitory
OB interneurons, including periglomerular cells and
granule cells, begin to differentiate in the lateral gangli-
onic eminences (LGEs) of the ventral telencephalon, mi-
grating tangentially into the OB [4-6]. Smaller numbers
of interneurons are also derived from the ventricular
zone (VZ) of the OB [7], and from subependymal pro-
genitors lining the lateral ventricles throughout life [8,9].
Development of the OB and OE are intimately inter-
twined. The OE is populated by OSNs that send pioneer
axons to infiltrate the primordial OB beginning
at ~ E11.5 in mouse [10,11]. Signals derived from pioneer
OSNs are thought to reduce relative rates of cell prolif-
eration in the rostral telencephalon, resulting in OB eva-
gination and tissue morphogenesis [11], events that
depend on Fgfr1 signaling [12]. There is also evidence
that OSN innervation influences neuronal migration in
the OB, as revealed by Dlx5, Fezf1 and Arx mutations, all
of which display defects in OSN innervation that are ac-
companied by the generation of a smaller OB and aber-
rant interneuron migration [13-16].
The proneural genes Neurog1 and Neurog2 encode
basic helix–loop–helix transcription factors that specify
a dorsal regional identity and glutamatergic neurotrans-
mitter phenotype in the neocortex [17-19]. Mitral, tufted
and juxtaglomerular cells are labeled in Neurog1 and
Neurog2 lineage traces, indicative of a pallial origin for
these OB neurons [1,20]. While Neurog1 mutants have
been reported to develop a smaller OB [21], the under-
lying cellular defects have not been characterized, and
the role of Neurog2 in OB development has yet to be
assessed. Moreover, while there is a partial loss of OSNs
in Neurog1−/− OEs [22,23], it is not known whether the
remaining OSNs differentiate normally. Here we find
that Neurog1/2 are required in a redundant fashion to
specify the identities of glutamatergic OB neurons, in-
cluding mitral and juxtaglomerular cells. Conversely we
show that only Neurog1 is required for OB morphogen-
esis and to promote the differentiation of OSNs and
their subsequent innervation of the OB. Neurog1/2 thus
coordinately regulate development of the olfactory
system.
Results
Neurog1 and Neurog2 are co-expressed in glutamatergic
lineages in the developing olfactory bulb
The proneural genes Neurog1 and Neurog2 are co-
expressed in dorsal telencephalic (that is, pallial) pro-
genitors [18,19,24], including those that give rise to
glutamatergic neuronal lineages in the neocortex and
OB [1,20]. To begin to assess how Neurog1 and Neurog2
might function together during OB development, wefirst compared their expression profiles at three key
time points: E11.5, prior to the onset of OB differenti-
ation; E12.5, when OB morphogenesis has initiated and
mitral cell projection neurons are differentiating, and
E13.5, when the first juxtaglomerular cells are born
[1-3,25]. At E11.5, Neurog1 transcripts were detected in
only a few cells in the VZ of the dorsal telencephalon,
including in the primordial OB at the rostral-most edge
(Figure 1A-A"). In contrast, Neurog2 was expressed
throughout the E11.5 pallial VZ, including in the pre-
sumptive OB (Figure 1B-B"). By E12.5 and at E13.5,
when the OB is visible as a morphological protrusion
[11,26], the number of neocortical and OB VZ cells
expressing Neurog1 steadily increased (Figure 1C-C",
E-E"), while Neurog2 expression remained widespread
throughout the neocortical and OB VZs (Figure 1D-D",
F-F"). Notably, at all stages analyzed, Neurog1 was also
widely expressed throughout the basal OE (Figure 1A-
A",C-C",E-E"), as previously documented [22], whereas
Neurog2 expression was limited to a small, ventromedial
OE domain (shown at E12.5; Figure 1D").
Immunostaining at E13.5 confirmed that Neurog1
and Neurog2 proteins were indeed co-expressed in pal-
lial progenitors, including in the presumptive neocor-
tex, as previously demonstrated [24], and in the
developing OB (Figure 1G). Recent long-term and
short-term fate-mapping studies have indicated that
Neurog1 [20] and Neurog2 [1] are expressed in all gluta-
matergic neuronal lineages in the OB, including mitral
and tufted cell projection neurons and juxtaglomerular
cells in the glomerular layer (GL). To determine to what
extent Neurog1 and Neurog2 were expressed in the
same or different OB lineages, we used a Neurog2GFP
knock-in (KI) allele (Neurog2KI) to perform short-term
GFP-lineage tracing of Neurog2-expressing cells and
their progeny [24]. The vast majority (if not all)
Neurog1-positive (Figure 1H) and Neurog2-positive
(Figure 1I) VZ progenitors in the OB co-expressed GFP,
suggesting that Neurog1 and Neurog2 are indeed co-
expressed within the same OB lineage(s). GFP expres-
sion also persisted in Neurog2+/KI OB cells migrating
out of the VZ, including those cells that had stopped
expressing Neurog1 and Neurog2, allowing the fate of
these cells to be assessed with molecular markers
(Figure 1J,K,L). GFP+ cells in the mantle layer of the
E13.5 Neurog2+/KI OB co-expressed Tbr1 (Figure 1J,J')
and Tbr2 (Figure 1K,K'), markers of dorsally-derived,
glutamatergic neurons [27,28], as recently reported [1].
In contrast, GFP+ cells did not express the ventral-
specific regional marker Dlx2 in E14.5 Neurog2+/KI
embryos (Figure 1L,L').
These data demonstrate that Neurog1 and Neurog2
are largely co-expressed in pallial progenitors, including
those that give rise to Tbr1+ and Tbr2+ glutamatergic
Figure 1 Neurog1 and Neurog2 expression in the embryonic olfactory system. (A) to (F) Sagittal sections of embryonic day (E) 11.5, E12.5
and E13.5 embryos, showing the distribution of Neurog1 (A-A", C-C", E-E") and Neurog2 (B-B", D-D", F-F") transcripts. Insets in A to F are fourfold
magnifications of the boxed areas in the OB (A' to F') and OE (A" to F"). (G) to (I) Co-immunolabeling of E13.5 Neurog2KI/+ brains with antibodies
to Neurog1 and Neurog2 (G), Neurog1 and GFP (H), and Neurog2 and GFP (I). Insets in (G) to (I) are fourfold magnifications of the boxed areas.
(J) to (L) Co-immunolabeling of the E13.5 OB with Tbr1 and GFP (J,J') and with Tbr2 and GFP (K,K'), and labeling of the E14.5 OB with Dlx2 and
GFP (L,L'). Boxed areas in (J) to (L) are magnified twofold in J', K', L' respectively. (M) Schematic representation of Neurog1 single-positive OE
progenitors (green) and Neurog1/Neurog2 double-positive progenitors (yellow) in the OB and a small region of the OE. (N) Schematic illustration
of the objectives of this study; to determine the roles of Neurog1 and Neurog2 in olfactory system development. dTel, dorsal telencephalon; OB,
olfactory bulb; OE, olfactory epithelium; vTel, ventral telencephalon. Scale bars: 1 mm (A) to (F), 250 μm (G) to (L), 125 μm (J') to (L').
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only Neurog1 is expressed to a significant extent in OE
lineages (Figure 1M), raising the question of how these
proneural genes coordinately regulate development of
the olfactory system (Figure 1N).
OB morphogenesis and lamination are disrupted in
Neurog1−/− and Neurog1/2−/− embryos
To determine whether Neurog1 and Neurog2 are required
for OB development, we used a loss-of-function approach,
analyzing Neurog1 [29] and Neurog2GFPKI [24] single and
double null mutants. In E18.5 wild-type (Figure 2A) and
Neurog2KI/KI mutant (Figure 2C) embryos, the OB was
visible as a distinct morphological protrusion of theFigure 2 Defects in olfactory bulb morphogenesis and lamination in
Whole-mount dorsal views of partially dissected embryonic day (E) 18.5 wil
all heterozygous or homozygous for a Neurog2GFPKI allele. Brains were left in
images. Arrowheads mark the reduction in OB size in Neurog1−/− embryos
GFP epifluorescence (green) and nuclear DAPI staining (blue) of sagittal sec
Neurog1/2−/− (H) OBs. (I) to (L) H & E histological analysis of E18.5 wild-type
(I') to (L') are twofold magnifications of the boxed areas in (I) to (L), respec
NCX, neocortex; OB, olfactory bulb; OBLS, olfactory bulb-like structure; ONL
500 μm (E) to (L), 250 μm (I') to (L').ventroanterior brain. In comparison, the OB was much
smaller in Neurog1−/− embryos (Figure 2B), and a mor-
phologically distinct OB was not apparent in Neurog1−/−;
Neurog2KI/KI double mutants (Neurog1/2−/−; Figure 2D).
To examine OB development at the cellular level, we first
monitored GFP expression from the Neurog2KI allele,
which serves as a short-term lineage trace of mitral, tufted
and juxtaglomerular lineages [1]. In E18.5 double hetero-
zygotes and Neurog2KI/KI and Neurog1−/− null mutants
(the latter maintained on a Neurog2KI/+ background),
GFP-labeled cells were detected in the OB VZ and devel-
oping mitral cell layer (MCL). In Neurog1−/− OBs, GFP+
cells in the glutamatergic OB lineages were disorganized
and formed a less distinct MCL (Figure 2E,F,G). Strikingly,Neurog1−/− and Neurog1−/−;Neurog2KI/KI mutant embryos. (A) to (D)
d-type (A), Neurog1−/− (B), Neurog2KI/KI (C), and Neurog1/2−/− (D) brains,
the cranium and imaged by merging bright-field and GFP fluorescent
(B), and apparent loss of the OB in Neurog1/2−/− embryos (D). (E) to (H)
tions through E18.5 wild-type (E), Neurog1−/− (F), Neurog2KI/KI (G), and
(I,I'), Neurog1−/− (J,J'), Neurog2KI/KI (K,K'), and Neurog1/2−/− (L,L') OBs.
tively. GCL, granule cell layer; Gl, glomerular layer; MCL, mitral cell layer;
, outer nerve layer; VZ, ventricular zone. Scale bars: 2 mm (A) to (D),
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brain, an OB-like structure (OBLS) with a central ventricle
that was surrounded by GFP+ cells was detected in an ab-
errant location in the ventrolateral brain (Figure 2H). To
further characterize the laminar organization of the pro-
neural mutant OBs, E18.5 sagittal sections were stained
with H & E. In H & E-stained wild-type (Figure 2I,I') and
Neurog2KI/KI (Figure 2K,K') mutant OBs, a distinct VZ,
granule cell layer, MCL, GL and outer nerve layer (ONL)
were apparent. In contrast, most of the post-mitotic neur-
onal layers were indistinct in the E18.5 Neurog1−/− OB
(Figure 2J,J') and Neurog1/2−/− OBLS (Figure 2L,L'), al-
though a VZ and granule cell layer were discernible in
both mutants.
We thus conclude that Neurog1 is required for proper
growth and lamination of the OB, whereas Neurog1 and
Neurog2 are together required for overall OB morpho-
genesis. We set out to identify the underlying cause(s)
for the morphological and laminar defects in these pro-
neural mutants.
Defects in the migration of glutamatergic neurons in
Neurog1−/− OBs and migration and differentiation in
Neurog1/2−/− OBLSs
The disruption of lamination in E18.5 Neurog1−/− OBs
and Neurog1/2−/− OBLSs suggested that the neuronal
subtypes that populate these layers may not differentiate
properly. To test this, we first examined glutamatergic
OB lineages, which are derived from Neurog1-expressing
and Neurog2-expressing pallial progenitors, including
projection neurons (mitral and tufted cells) and inter-
neurons (juxtaglomerular cells) (see above, and [1,20]).
To label projection neurons in the MCL, we used a
panel of dorsal telencephalic-specific markers, including
NeuroD6, Tcfap2e, Nrp1, NeuroD1, Reelin, Tbr1 and
Tbr2 (Figure 3 and data not shown). Notably, Tcfap2e
also labels OB progenitors, and is one of the few defini-
tive markers of an OB identity as it is not also expressed
in neocortical lineages [30], unlike the rest of the mar-
kers we employed. To unambiguously identify the OBLS
in Neurog1/2−/− double mutants, the anterior olfactory
nucleus (AON), which lies between the neocortex and
OB, was used as a landmark. In E18.5 Neurog2KI/+
embryos, the AON was labeled by GFP (data not
shown), indicating that it is also derived from Neurog2-
expressing pallial progenitors. In all E18.5 Neurog1/2
single and double mutants, the AON expressed GFP
(data not shown), Neurod6 (Figure 3A,B,C,D) and Tbr1
(data not shown), indicating that AON development is
not grossly perturbed by the loss of these proneural
genes.
In the main OB, expression of NeuroD6, Tcfap2e, Tbr1
and Tbr2 was detected in the OB VZ and MCL in E18.5
wild-type and Neurog2KI/KI null embryos (Figure 3A,C,E,G,I,K,M,O). In contrast, NeuroD6, Tcfap2e, Tbr1 and
Tbr2-expressing cells were generated, but were disorga-
nized in E18.5 Neurog1−/− OBs, occupying ectopic posi-
tions in the outermost portion of the OB, where a mitral
cell-deficient GL would normally form (Figure 3B,F,J,N).
Strikingly, NeuroD6, Tcfap2e, Tbr1 and Tbr2 expression
was also detected in the aberrantly localized OBLS in
E18.5 Neurog1/2−/− embryos, although the number of
Tcfap2e-positive cells was markedly reduced (Figure 3D,
H,L,P). Neurog1/2 are thus required for the lamination
of MCL projection neurons in the OB, and may together
be required for the differentiation of these cells.
We next asked whether Neurog1/2 were required for
the differentiation of glutamatergic juxtaglomerular cells
in the GL, which includes external tufted and short axon
cells that are labeled by vesicular glutamate transporter
1 (vGlut1) and vGlut2 [1,31,32]. In E18.5 wild-type
(Figure 3Q,U) and Neurog2KI/KI (Figure 3S,W) OBs,
vGlut1 labeled a large number of juxtaglomerular cell
bodies and their projections, while vGlut2 expression
was confined to the ONL in the periphery of the GL. In
Neurog1−/− OBs, vGlut1 and vGlut2 staining was
strongly reduced in the presumptive GL, and an ectopic
cluster of vGlut1/2-labeled cells aggregated in the dorsal
OB (Figure 3R,V). Similarly, while scattered vGlut1/2-
immunoreactive cells were detected throughout the
Neurog1/2−/− OBLS, a distinct GL was not evident in
these embryos (Figure 3T,X).
Finally, to quantitate glutamatergic neurons in the OB,
we analyzed the expression of Tbr2, a pan-glutamatergic
neuronal marker, and Tbr1, which labels MCL projec-
tion neurons and short axon juxtaglomerular cells in the
GL (Figure 4A to J). Cell counts were performed at
E13.5, when the vast majority of glutamatergic OB neu-
rons have differentiated [1-3]. We observed a significant
reduction in the number of Tbr1+ (wild-type and
Neurog2KI/KI, n= 4; Neurog1−/− and Neurog1/2−/−, n= 3)
and Tbr2+ (wild-type and Neurog2KI/KI, n= 4; Neurog1−/−
and Neurog1/2−/−, n= 3) glutamatergic neurons only in
the Neurog1/2−/− double-mutant OBLS compared with
wild-type OBs (P <0.05 for both Tbr1 and Tbr2 counts;
Figure 4I,J).
We thus conclude that glutamatergic mitral and juxta-
glomerular cells are born in normal numbers in Neu-
rog2KI/KI and Neurog1−/− single-mutant OBs, but these
cells migrate inappropriately and fail to take up their cor-
rect positions in the Neurog1−/− MCL and GL. In contrast,
fewer glutamatergic neurons are born in the Neurog1/2−/−
OBLS, and these cells also migrate aberrantly.
Neurog1 is upregulated in Neurog2−/− olfactory bulbs
The lack of an apparent defect in the Neurog2−/− OB (at
least at the morphological level and in glutamatergic
lineages) was surprising given that fewer glutamatergic
Figure 3 Impaired lamination and differentiation of excitatory neurons in Neurog1/2−/− single and double mutant olfactory bulbs. (A)
to (X) Expression of NeuroD6 (A) to (D), Tcfap2e (E) to (H), Tbr1 (I) to (L), Tbr2 (M) to (P), vGlut1 (green)/DAPI (blue) (Q) to (T) and vGlut2 (green)/DAPI
(blue) (U) to (X) in embryonic day 18.5 wild-type (A,E,I,M,Q,U), Neurog1−/− (B,F,J,N,R,V), Neurog2KI/KI (C,G,K,O,S,W) and Neurog1/2−/− (D,H,L,P,T,X) olfactory
bulbs (OBs). White arrowheads in R,V,T,X mark diminished vGlut1/2 protein expression in the peripheral glomerular layer (GL). AON, anterior olfactory
nucleus; MCL, mitral cell layer; OBLS, olfactory bulb-like structure; VZ, ventricular zone. Scale bars: 1 mm (A) to (D), 500 μm (E) to (X).
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cortices. We previously attributed the Neurog2−/− neo-
cortical phenotype to a downregulation of Neurog1
expression in dorsomedial telencephalic domains, suchthat Neurog2−/− and Neurog1/2−/− embryos are equiva-
lent (that is, both lack Neurog1 and Neurog2 expression)
in this part of the developing neocortex [18]. We there-
fore asked whether Neurog1 expression was similarly lost
Figure 4 Defects in the differentiation of glutamatergic olfactory bulb neurons in Neurog1/2 double mutants. (A) to (H) Expression of
Tbr1 (A) to (D) and Tbr2 (E) to (H) in the presumptive MCL of embryonic day (E) 13.5 wild-type (A,E), Neurog1−/− (B,F), Neurog2KI/KI (C,G) and
Neurog1/2−/− (D,H) OBs. White arrowheads in D,H mark the reduction in glutamatergic neurons in Neurog1/2−/− OBs. White asterisks in (A) to (H)
mark the ventricular zone. (I), (J) Quantitation of total numbers of Tbr1+ cells (I) and Tbr2+ cells (J) in E13.5 wild-type Neurog1−/−, Neurog2KI/KI and
Neurog1/2−/− OBs. Asterisks denote P <0.05. (K) to (N) Analysis of Neurog1 expression in E11.5 (K,L) and E13.5 (M,N) wild-type and Neurog2−/−
telencephalons. Arrows mark ectopic Neurog1 expression in (L) and (N). Scale bars: 250 μm (A) to (H), 1 mm (K) to (N).
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Strikingly, we found that Neurog1 was instead upregu-
lated in the Neurog2−/− rostral telencephalon (presumptiveOB) at both E11.5 (Figure 4K,L) and to a lesser extent at
E13.5 (Figure 4M,N). In contrast, Neurog1 expression was
reduced throughout most of the remainder of the
Shaker et al. Neural Development 2012, 7:28 Page 8 of 22
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ted [18]. These data are consistent with the idea that Neu-
rog1 may compensate for the loss of Neurog2 in the
developing OB.
Relative rates of OB proliferation are elevated in
Neurog1−/− and Neurog1/2−/− OBs
Beginning at ~ E12.5, the OB is first evident as a distinct
rostral protuberance of the telencephalon [11,26]. In our
analysis of glutamatergic neuronal markers, we observed
a shortening of the proximal–distal telencephalic axis in
Neurog1−/− mutants as early as E13.5, while a morpho-
logically distinct OB was not evident in Neurog1/2−/−
mutants at any stage analyzed (between E12.5 and E18.5;
data not shown). At these early stages, the driving force
of OB morphogenesis is thought to be a reduction in
proliferation at the rostral edge of the telencephalon,
which results in the neocortex ballooning out while the
presumptive OB is left behind [11,26]. To determine
whether aberrant patterns of proliferation contributed to
the morphogenetic defects observed in Neurog1−/− and
Neurog1/2−/− OBs, dividing S-phase progenitors were la-
beled with a 30-minute BrdU pulse and labeled progeni-
tors were then enumerated in fields of equal size in the
presumptive neocortex (dorsal telencephalon) and OB
(Figure 5A to K). The presumptive OB was identified at
these early stages as the midpoint of the telencephalic
continuum surrounding the lateral ventricles. Specific-
ally, the OB is flanked by dorsal and ventral telencepha-
lic domains, both of which have distinct morphological
features, and the borders of which were precisely identi-
fied by BrdU co-labeling with Tbr2 (dorsal) or Dlx2
(ventral).
OB/dorsal telencephalic proliferation ratios were com-
pared across all Neurog1/2 genotypes. At E11.5, when
the OB is not yet distinct, the ratio of S-phase progeni-
tors in the OB versus dorsal telencephalon was similar
in wild-type embryos (83.3 ± 6.5%, n= 4; Figure 5A,J),
Neurog1−/− embryos (102.6 ± 5.1%, P >0.05, n= 4;
Figure 5B,J) and Neurog2KI/KI embryos (105.0 ± 9.9%,
P >0.05, n= 3; Figure 5C,J). In contrast, the ratio of
BrdU-labeled progenitors in the OB versus dorsal telen-
cephalon was 120.5 ± 6.7% in E11.5 Neurog1/2−/− double
mutants, 1.4-fold higher than in wild-type embryos
(P= 0.02, n= 3; Figure 5D,J). OB proliferation rates are
thus aberrantly high in Neurog1/2−/− double mutants as
early as E11.5.
We next examined proliferating pallial progenitors
at E13.5, when the OB is morphologically distinct
(Figure 5E,F,G,H,K). In E13.5 wild-type embryos, the
ratio of BrdU-labeled VZ progenitors in the OB versus
dorsal telencephalon had declined to 56.3 ± 1.6% (n = 5;
Figure 5E,K), indicative of a reduction in relative rates
of OB proliferation, consistent with previous reports[11,12,26]. In E13.5 Neurog2KI/KI embryos, which de-
velop a morphologically normal OB, a similar OB/dor-
sal telencephalon proliferation ratio was observed
(52.8 ± 3.5%, n = 3; Figure 5G,K). In contrast, the ratio
of proliferating progenitors in the OB versus dorsal tel-
encephalon was aberrantly high in E13.5 Neurog1−/−
OBs (90.4 ± 14.0%, P <0.001, n = 3; Figure 5F,K) and
Neurog1/2−/− OBLSs (109.5 ± 3.7%, P <0.001, n = 3;
Figure 5H,K).
To confirm that the OB/dorsal telencephalon prolif-
eration ratios were not altered in Neurog1 or Neurog2
single mutants because of a defect in the neocortex (as
opposed to OB), we also compared the ratios of BrdU+
cells in the dorsal versus ventral telencephalon
(Figure 5L,M,N). Note that neither Neurog1 nor Neurog2
are expressed in the ventral telencephalon, so prolifera-
tion rates should not be altered in this domain in
mutants (serving as an internal control). Consistent with
the lack of a defect in neocortical cell proliferation in
Neurog1/2 single and double mutants, at both E11.5
(Figure 5M) and E13.5 (Figure 5N), the ratios of BrdU-
labeled ventral versus dorsal telencephalic progenitors
were similar in all genotypes (P >0.05 for all pairwise
comparisons against wild-type). We thus conclude that
prospective OB progenitors fail to reduce their relative
proliferation rates in Neurog1−/− and Neurog1/2−/−
mutants, probably contributing to the observed OB mor-
phogenesis defects.
To further characterize proliferation defects in early
OB development, we examined the spatial arrangement
of BrdU-labeled S-phase progenitors in the E13.5 VZ
with respect to differentiating mitral cells. Early-born
mitral cells migrate radially from the OB VZ, using ra-
dial glia as a scaffold, while later-born mitral cells shift
to a tangential pattern of migration, coursing through
the intermediate zone of the OB in close proximity to
tangentially oriented axons of early-born mitral cells
[10,33]. Consequently, mitral cells generated at E10
show a bias towards dorsomedial positions, while tan-
gentially migrating cells born at E12 preferentially accu-
mulate in ventrolateral domains. In E13.5 wild-type OBs
(Figure 5O) and Neurog2KI/KI OBs (Figure 5Q), Tbr2+
mitral cells had migrated throughout the mantle layer of
the OB, lining the OB surface along the entire dorsal-to-
ventral axis, but were less abundant in a central zone at
the rostral tip. In E13.5 Neurog1−/− OBs (Figure 5P), the
distribution of Tbr2+ cells was altered, such that a Tbr2-
deficient zone at the rostral tip was not observed,
suggestive of early defects in cell migration. These mi-
gratory defects were more severe in E13.5 Neurog1/2−/−
OBLSs, in which a distinct gap was evident between the
BrdU-labeled progenitor zone and the Tbr2+ mantle
layer (Figure 5R). Migration defects are thus evident as
early as E13.5 in Neurog1−/− and Neurog1/2−/− OBs.
Figure 5 (See legend on next page.)
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Figure 5 Aberrant patterns of cell proliferation in Neurog1/2−/− mutants. (A) to (H) BrdU-labeled S-phase progenitors at embryonic day (E)
11.5 (A) to (D), and E13.5 (E) to (H) in wild-type (A,E), Neurog1−/− (B,F), Neurog2KI/KI (C,G), and Neurog1/2−/− (D,H) OBs. (I) to (K) Illustration schematizing
areas where counts of BrdU-labeled S-phase progenitors were performed (I). Quantitation of the ratio of BrdU+ cells in the OB compared with the
dorsal telencephalon at E11.5 (J) and E13.5 (K). Asterisks denote P <0.05. (L) to (N) Illustration schematizing areas where counts of BrdU-labeled
S-phase progenitors were performed (L). Quantitation of the ratio of BrdU+ cells in the ventral compared with the dorsal telencephalon at E11.5 (M)
and E13.5 (N). (O) to (V) Co-labeling of BrdU+ S-phase progenitors (green) with either Tbr2 (red, O to R) or Dlx2 (red, S to V) in E13.5 wild-type (O,S),
Neurog1−/− (P,T), Neurog2KI/KI (Q,U), and Neurog1/2−/− (R,V) embryos. dTel, dorsal telencephalon; OB, olfactory bulb; pOB, presumptive olfactory bulb;
pOBLS, presumptive olfactory bulb like structure; vTel, ventral telencephalon. Scale bars: 250 μm (A) to (H), (O) to (V).
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bulb interneurons in Neurog1−/−, Neurog2KI/KI and
Neurog1/2−/− mutants
In the embryonic neocortex, Neurog1 and Neurog2
regulate a binary fate decision, promoting a dorsal re-
gional identity and glutamatergic neurotransmitter
phenotype while repressing an alternative ventral,
GABAergic neuronal identity [18,19]. We thus specu-
lated that the reduction in glutamatergic neuronal num-
ber in the Neurog1/2−/− OBLS may be due to a similar
fate switch. To test this, E13.5 embryos were labeled
with Dlx2, which together with Dlx1 is required for the
generation of almost all GABAergic and dopaminergic
interneurons in the OB [13,34,35]. While Dlx2 was
widely expressed in the mantle zone of the E13.5 ventral
telencephalon, only a few Dlx2+ cells had infiltrated the
wild-type (Figure 5S) and Neurog1−/− (Figure 5T) OBs
at this stage. In contrast, Dlx2-labeled neurons were
abundant in the E13.5 Neurog1/2−/− OBLS (Figure 5V),
lying directly adjacent to the BrdU-labeled progenitor
zone in the VZ, and filling the gap between the Tbr2+
and BrdU+ zones. Some Dlx2+ cells were also detected
in ectopic sites in the Neurog2KI/KI OB (Figure 5U).
Interneurons thus appeared to be generated at the ex-
pense of glutamatergic neurons in the Neurog1/2−/−
OBLS, and possibly also in Neurog2KI/KI OBs.
In the neocortex, the ventralization of Neurog2KI/KI
and Neurog1/2−/− progenitors arises due to the increased
expression of Ascl1 [18,19], a proneural gene that is
required for the generation of GABAergic neurons in
the ventral telencephalon [36,37], and a subset of peri-
glomerular cells in the embryonic OB [35] and adult OB
[38]. Ascl1 expression was also upregulated in the E13.5
OB VZ in Neurog2KI/KI and Neurog1/2−/− embryos
(Figure 6A,B,C,D), consistent with a similar mechanism
underlying the misspecification of OB neurons. To fur-
ther analyze the ectopic differentiation of OB interneur-
ons, E18.5 OBs were analyzed for the expression of
Dlx1, which labels OB progenitors and postmitotic gran-
ule and periglomerular cells in the granule cell layer and
GL, as well as glutamate decarboxylase 1 (GAD1), which
labels all GABAergic OB interneurons in the granule cell
layer and GL [39], calretinin, which labels most granule
cells and a subset of periglomerular cells [6], and TH,which labels dopaminergic periglomerular cells (Figure 6E
to T) [6]. In E18.5 Neurog1−/− OBs, a distinct GL was not
evident, and instead, neurons labeled with Dlx1, GAD1,
and calretinin and TH were scattered throughout the
mantle zone of the OB (Figure 6F,J,N,R). In E18.5 Neu-
rog2KI/KI OBs, the GL was clearly marked by Dlx1, GAD1,
and calretinin, but a scattering of ectopic interneurons la-
beled by these markers was also detected between the
MCL and GL (Figure 6G,K,O). While TH+ cells were not
located in ectopic sites in E18.5 Neurog2KI/KI OBs, they
formed a less compact layer (Figure 6S). Finally, in Neu-
rog1/2−/− OBLSs, there was a striking expansion of Dlx1,
GAD1, calretinin and TH expression domains, which
spread out radially from the VZ of the OBLS to reach the
pial surface of the brain (Figure 6H,L,P,T).
Aberrantly positioned OB interneurons could signify
an increase in migration from ventral domains or a
respecification of dorsal progenitors to acquire an aber-
rant ventral identity. While our previous results in the
neocortex favor a respecification model, to formally test
this, we performed Neurog2 short-term lineage tracing
with the Neurog2GFPKI allele. Note that we have exten-
sively compared molecular marker expression in wild-
type and Neurog2KI/+ brains (including the OB) and
have no evidence for a heterozygous phenotype. We
therefore analyzed GFP co-expression with three
transcription factors expressed in OB interneuron popu-
lations [40]; namely Sp8, which is expressed in calreti-
nin+, parvalbumin+ and GABAergic periglomerular and
granule cells [41,42]; Pax6, which is required to generate
the majority of granule cells along with dopaminergic
(TH+) periglomerular cell progenitor subtypes [43,44];
and Er81, which labels VZ progenitors, granule cells and
dopaminergic periglomerular cells [45]. As expected,
minimal GFP/Sp8 co-labeling was detected in E18.5
Neurog2KI/+ (that is, wild-type control; Figure 7A,M)
and Neurog2KI/+;Neurog1−/− OBs (Figure 7B,M). In con-
trast, in E18.5 Neurog2KI/KI OBs (4.2-fold increase;
P <0.001; Figure 7C,M) and Neurog1/2−/− OBLSs (5.5-
fold increase; P <0.0001; Figure 7D,M) there was a sig-
nificant increase in number of GFP/Sp8 co-labeled
cells throughout the OB. Similarly, the numbers of
Pax6+GFP+ (Figure 7E,F,G,H,N) and Er81+GFP+
(Figure 7I,J,K,L,O) double-positive interneurons were
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4.07-fold increase, P <0.05; Er81+GFP+: 1.87-fold in-
crease, P <0.05) and Neurog1/2−/− OBLSs (Pax6+GFP+:
4.52-fold increase, P <0.05; Er81+GFP+: 1.83-fold in-
crease, P <0.05).
In Neurog2KI/KI OB and Neurog1/2−/− OBLSs, there-
fore, a subset of pallial progenitors that should give rise
to glutamatergic OB projection neurons are misspecified,
instead differentiating into GABAergic interneurons. In
contrast, neuronal misspecification defects are not
observed in Neurog1−/− OBs, although the migration of
GABAergic OB neurons is strikingly perturbed.
Olfactory sensory neurons fail to innervate the olfactory
bulb in Neurog1−/− and Neurog1/2−/− embryos
At first glance, the defective migration of OB interneurons
in Neurog1−/− and Neurog1/2−/− embryos was unexpected,
given that these proneural genes are not expressed in OB
interneuron lineages [20]. However, several studies have
indicated that OSN innervation is required for OB inter-
neuron migration [13-16], in addition to controlling the
proliferation of OB progenitors [11]. Defects in OB inter-
neuron migration could thus be non-cell autonomous in
Neurog1−/− and Neurog1/2−/− double mutants. Consistent
with this model, Neurog1 is expressed in OE progenitors,
where it is required for the differentiation of a subset of
OSNs at early stages of development [22], although in-
nervation patterns were not examined.
To determine whether OSN innervation was indeed
perturbed in the absence of Neurog1 function, we moni-
tored the expression of growth-associated protein 43
(GAP43) and olfactory marker protein (OMP), which
mark both the cell bodies and axonal projections of im-
mature (GAP43) and mature (OMP) OSNs [11,46]. In
coronal sections through E18.5 wild-type (Figure 8A,E)
and Neurog2KI/KI (Figure 8C,G) OBs, GAP43-labeled and
OMP-labeled OSN axons emanated from the OE, tra-
versing the cribriform plate to penetrate the ONL, where
they wrapped the entire periphery of the OB. In
contrast, in E18.5 Neurog1−/− (Figure 8B,F) and Neu-
rog1/2−/− (Figure 8D,H) embryos, GAP43 and OMP la-
beled a fibrocellular mass (FCM) that did not penetrate
the OB. Only a small amount of GAP43 and OMP ex-
pression was observed surrounding caudal regions of the
Neurog1−/− OB, suggesting that very few OSN axons
innervated the mutant OB (Figure 8B,F). As a side note,
the term FCM was first coined to describe the extratoes
(that is, Gli3−/−) olfactory phenotype, and refers to an
amorphous bundle of OSN axons that fail to extend and
penetrate the OB [47]. To assess OSN innervation along
the entire rostrocaudal axis, we also examined sagittal
sections of E18.5 Neurog1−/− (Figure 9B,F) and Neurog1/2−/−
(Figure 9D,H) embryos with calretinin (data not shown),
GAP43 (Figure 9A,B,C,D) and OMP (Figure 9E,F,G,H),revealing that defects in OSN axon innervations of the OB
were observed at all levels.
OSNs express one of ~1,200 odorant receptors (OR)
in mice, dictating the type of odor they will respond to,
with OSNs that express the same OR targeting the iden-
tical glomerulus in the OB [48-50]. Notably, the specifi-
city of OSN targeting depends on ORs, which are
functionally required to establish a glomerular topo-
graphic map in the OB [51-53]. To determine whether
OR expression was maintained in Neurog1/2−/− OSNs,
we examined the expression of three different ORs (L45,
M72, P2) that direct the innervation of distinct glom-
eruli [54,55]. In coronal sections through E18.5 wild-
type OBs (Figure 8I,M,Q) and Neurog2KI/KI OBs
(Figure 8K,O,S), L45, M72 and P2 transcripts were
detected in OSN axon bundles that had innervated the
OB, concentrating in the ventromedial ONL. In contrast,
in E18.5 Neurog1−/− embryos (Figure 8J,N,R) and
Neurog1/2−/− embryos (Figure 8L,P,T), L45, M72 and P2
were expressed in OSN axons that accumulated in a
FCM outside the OB. Neurog1−/− and Neurog1/2−/−
OSN axons therefore failed to penetrate the OB, even
though they continued to express ORs.
We next searched for molecular signals that may ac-
count for the lack of OSN innervation in Neurog1−/−
and Neurog1/2−/− OBs. Neurotrophins (NGF, BDNF,
NT3) and their cognate receptors (Ntrk1, Ntrk2, Ntrk3)
regulate several cellular processes, including neuronal
survival, differentiation and axonal and dendritic growth
(reviewed in [56]). The ligands BDNF, NGF and NT3
and the receptors Ntrk1, Ntrk2 and Ntrk3 are all
expressed in the olfactory system reviewed in [56]. In
sagittal sections through E18.5 wild-type OBs/OEs
(Figure 9I,M,Q,U,Y,C') and Neurog2KI/KI OBs/OEs
(Figure 9K,O,S,W,A',E'), BDNF, NGF, NT3, Ntrk1, Ntrk2
and Ntrk3 were all expressed in a similar fashion, mark-
ing OSN axons exiting the OE and innervating the ONL
of the OB. In contrast, in E18.5 Neurog1−/− embryos
(Figure 9J,N,R,V,Z,D') and Neurog1/2−/− embryos
(Figure 9L,P,T,X,B',F'), BDNF, NGF, NT3, Ntrk1, Ntrk2
and Ntrk3 transcripts accumulated in FCMs between the
OB and OE, consistent with the inability of OSNs to in-
nervate the OB in these two mutant backgrounds.
Taken together, these data show that Neurog1−/− and
Neurog1/2−/− mutant OSNs fail to innervate the OB,
despite their expression of several markers of differen-
tiated OSNs. Neurog1 is thus required to promote OSN
axonal extension into the ONL of the OB.
Olfactory sensory neurons and olfactory ensheathing cells
express appropriate differentiation markers in Neurog1−/−
and Neurog1/2−/− embryos
To better understand why Neurog1−/− and Neurog1/2−/−
OSN axons did not penetrate the OB/OBLS, we
Figure 6 Ectopic differentiation of olfactory bulb interneurons in Neurog2KI/KI and Neurog1/2−/− embryos. (A) to (D) Expression of Ascl1 in
embryonic day (E) 13.5 wild-type (A), Neurog1−/− (B), Neurog2KI/KI (C), and Neurog1/2−/− (D) OBs. (E) to (T) Expression of Dlx1 (E) to (H), Gad1 (I) to
(L), calretinin (CR) (M) to (P) and TH (Q) to (T) in E18.5 wild-type, (E,I,M,Q), Neurog1−/− (F,J,N,R), Neurog2KI/KI (G,K,O,S), and Neurog1/2−/− (H,L,P,T)
OBs. Blue is DAPI nuclear stain in (M) to (T). Arrowheads in (C,D) mark the upregulated expression of Ascl1 in the OB of Neurog2KI/KI and OBLS of
Neurog1/2−/− embryos. Arrowheads in (H,L,P,T) mark expansion of expression domain from VZ to pial surface in Neurog1/2−/− OBs. Asterisks in (F,J,
N,R) mark ectopic interneurons in Neurog2KI/KI OBs. dTel, dorsal telencephalon; GL, glomerular layer; GCL, granule cell layer; MCL, mitral cell layer;
OB, olfactory bulb; OBLS, olfactory bulb-like structure; ONL, olfactory nerve layer; vTel, ventral telencephalon; VZ, ventricular zone. Scale bars: 500
μm (A) to (T).
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was shown that fewer OSNs express a subset of differen-
tiation markers in the E12.5 Neurog1−/− OEs [22]. Here
we examined OSN differentiation at E18.5, using the
pan-neuronal marker SCG10 (Figure 10A,B,C,D) and the
mature OSN marker OMP (Figure 10E,F,G,H). Strik-
ingly, there was only a slight reduction in the number of
SCG10-labeled and OMP-labeled OSNs in medial
domains of the E18.5 Neurog1−/− OEs (Figure 10B,F)and Neurog1/2−/− OEs (Figure 10D,H) compared
with E18.5 wild-type embryos (Figure 10A,E) and
Neurog2KI/KI embryos (Figure 10C,G). A significant
number of OSNs thus differentiate by E18.5 in Neurog1−/−
and Neurog1/2−/− OEs, despite the earlier block in
differentiation [22].
We next examined the differentiation of olfactory en-
sheathing cells (OECs), which arise in the olfactory pla-
code and wrap around OSN axonal tracts to provide
Figure 7 Neuronal misspecification defects in Neurog2−/− olfactory bulbs and Neurog1/2−/− olfactory bulb-like structures. (A) to (L) Co-
immunostaining of GFP (green, A to L) with Sp8 (red, A to D), Pax6 (red, E to H) or Er81 (red, I to L) in E18.5 wild-type, (A,E,I), Neurog1−/− (B,F,J),
Neurog2KI/KI (C,G,K), and Neurog1/2−/− (D,H,L) OBs. Insets to the right of each panel are fourfold magnifications of boxed areas. (M) to (O)
Quantitation of total Sp8+GFP+ cells (M), Pax6+GFP+ cells (N), and Er81+GFP+ cells (O) in embryonic day 18.5 wild-type, Neurog1−/−, Neurog2KI/KI
and Neurog1/2−/− OBs. *P <0.05, **P <0.01, ***P <0.005. GCL, granule cell layer; GL, glomerular layer; MCL, mitral cell layer; VZ, ventricular zone.
Scale bars: 500 μm (A) to (L).
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[57,58]. NCAM, which is expressed in OSNs and OECs,
and p75, which specifically labels OECs, co-labeled the
olfactory nerve, which infiltrated the ventral surface of
the OB in E18.5 wild-type (Figure 10I) and Neurog2KI/KI
(Figure 10K) OEs. In contrast, while NCAM and p75
were co-expressed in the olfactory nerve in E18.5Neurog1−/− embryos (Figure 10J) and Neurog1/2−/−
embryos (Figure 10L), the OEC-wrapped OSNs termi-
nated in a FCM between the OB and OE. Labeling of
OECs with S100b similarly revealed that OECs infiltrate
the ventral OB in wild-type embryos (Figure 10M) and
Neurog2KI/KI embryos (Figure 10O), whereas OECs accu-
mulate in a FCM in Neurog1−/− embryos (Figure 10N)
Figure 8 Neurog1−/− and Neurog1/2−/− olfactory sensory neurons express mature markers but fail to innervate olfactory bulb. (A) to (H)
Coronal sections of the embryonic day (E) 18.5 OB showing expression of GAP43 (red, A to D) and OMP (green, E to H) with DAPI (blue, A to H)
in wild-type (A,E), Neurog1−/− (B,F), Neurog2KI/KI (C,G) and Neurog1/2−/− (D,H) embryos. Yellow arrows denote loss of OSN innervation of the OB in
Neurog1−/− and Neurog1/2−/− (B,D,F,H) embryos. (I) to (T) Expression of odorant receptors L45 (I) to (L), M72 (M) to (P) and P2 (Q) to (T) in E18.5
wild-type (I,M,Q), Neurog1−/− (J,N,R), Neurog2KI/KI (K,O,S) and Neurog1/2−/− (L,P,T) embryos. Note that the lack of an apparent OB in Neurog1−/−
sections is because the OB is shortened along the proximodistal axis, and hence does not fill the rostral-most part of the cavity in the skull, where
OR expression levels are the highest (J,N,R). GAP43, growth-associated protein 43; OB, olfactory bulb; OE, olfactory epithelium; OMP, olfactory
marker protein; OSN, olfactory sensory neuron. Scale bars: 500 μm (A) to (T).
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OECs thus differentiate in all Neurog1/2 genotypes, but
they fail to innervate the OB in Neurog1−/− and Neu-
rog1/2−/− embryos.
Finally, we investigated whether apoptosis may contrib-
ute to the small decline in OSN numbers in Neurog1−/−
and Neurog1/2−/− mutants by analyzing the expression
of activated caspase 3, a marker of apoptosis. In E14.5wild-type OEs (Figure 10Q), Neurog1−/− OEs (Figure 10R)
and Neurog2KI/KI OEs (Figure 10S), only a few scattered
activated caspase 3-positive cells were detected, whereas in
Neurog1/2−/− embryos (Figure 10T) there was a notable
increase in activated caspase 3 immunolabeling in the
OE. Apoptosis thus occurs at elevated levels in the
Neurog1/2−/− OE only, despite Neurog2 not being
expressed in the vast majority of OE progenitors.
Figure 9 (See legend on next page.)
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Figure 9 Neurog1−/− and Neurog1/2−/− olfactory sensory neurons express neurotrophic receptors and ligands but fail to innervate
olfactory bulb. (A) to (H) Expression of GAP43 (red, A to D) and OMP (green, E to H) with DAPI counterstain (blue, A to H) in embryonic day (E)
18.5 wild-type (A,E), Neurog1−/− (B,F), Neurog2KI/KI (C,G) and Neurog1/2−/− (D,H) OBs/OEs. White arrows denote loss of synaptogenesis between the
OE and the OB in Neurog1−/− and Neurog1/2−/− (B,D,F,H) olfactory systems, and arrowheads point to the accumulation of OSN axons in a FCM. (I)
to (T) Expression of Ntrk1 (I) to (L), Ntrk2 (M) to (P) and Ntrk3 (Q) to (T) in E18.5 wild-type (I,M,Q), Neurog1−/− (J,N,R), Neurog2KI/KI (K,O,S) and
Neurog1/2−/− (L,P,T) embryos. (U) to (F') Expression of BDNF (U) to (X), NGF (Y) to (B'), NT3 (C') to (F'), in E18.5 wild-type (U,Y,C'), Neurog1−/− (V,Z,
D'), Neurog2KI/KI (W,A',E') and Neurog1/2−/− (X,B',F') embryos. Black arrows (J,L,N,P,R,T,V,X,Z,B',D',F') indicate loss of marker expression in outer
layers of Neurog1−/− and Neurog1/2−/− OBs. Arrowheads (J,L,R,T,V,X,Z,B',D',F') point to FCM formation in Neurog1−/− and Neurog1/2−/− embryos.
FCM, fibrocellular mass; OB, olfactory bulb; OBLS, olfactory bulb-like structure; OE, olfactory epithelium; ONL, olfactory nerve layer. Scale bars: 500
μm (A) to (Z), (A') to (F').
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mutants phenocopies the OE defects observed upon
bulbectomy [59], suggesting that the Neurog1/2−/−
OBLS may fail to provide trophic signals to the OE, as
discussed further below.
Discussion
The olfactory system consists of the OB, OE and olfac-
tory cortex, which together are responsible for detecting
and processing odors (Figure 10U). Here we provide
mechanistic insights into how the development of these
olfactory structures is coordinated. We first demonstrate
that Neurog1 and Neurog2 function redundantly and in a
cell autonomous fashion to specify the glutamatergic
neuronal identity of OB projection neurons and juxta-
glomerular cells, while suppressing an alternative inter-
neuron fate. In contrast, only Neurog1 is required to
regulate OSN innervation of the OB, defects in which
can perturb the proliferation rate of OB progenitors, and
the migratory routes of OB neurons (Figure 10V,W). In
summary, Neurog1 and Neurog2 play an integral role in
coordinately regulating development of the olfactory sys-
tem, regulating cell fate specification in the OB and
OSN differentiation and axonal targeting in the OE.
Neurog1/2 promote a glutamatergic neuronal identity in
the olfactory bulb
Glutamatergic mitral, tufted and juxtaglomerular cells
are derived from dorsal telencephalic progenitors, as
revealed by Neurog1 [20] and Neurog2 (present study
and [1]) lineage tracing. Accordingly, we found that
fewer glutamatergic OB neurons are generated in the ab-
sence of Neurog1/2 function. Nevertheless, a subset of
mitral and juxtaglomerular cells differentiate in the
Neurog1/2−/− OBLS, suggesting that other genes com-
pensate for the loss of proneural function. Candidate
transcriptional regulators that may promote the differen-
tiation of glutamatergic OB neurons in the absence of
Neurog1/2 include the cortical selector genes Pax6
[3,60] and Lhx2 [61], both of which are also required
for the differentiation of subsets of glutamatergic neur-
onal lineages in the OB. Consistent with a potentialcompensatory role for Pax6 in the OB, in the embryonic
neocortex, we previously demonstrated that Neurog1/2
are required for the first wave of neurogenesis (<E14.5),
whereas Pax6 drives the second wave (>E14.5) [19].
At first glance, the presence of OB defects in Neurog1−/−
and not Neurog2−/− single mutants might suggest that
these two transcription factors have distinct functions.
However, we show here that Neurog1 is upregulated in the
presumptive OB of Neurog2−/− single mutants, probably
compensating for the loss of Neurog2. We thus suggest that
Neurog1 and Neurog2 are for the most part functionally re-
dundant in the developing OB. Consistent with this idea,
only in Neurog1/2−/− double mutants are severe defects in
OB development observed.
OB and neocortical projection neurons differ, yet both
arise from adjacent pools of dorsal telencephalic pro-
genitors. How does neuronal diversification occur? One
possibility is that OSN-derived or OEC-derived signals
alter the cell-fate specification functions of Neurog1/2.
Consistent with this idea, at ~ E11 when mitral cells
begin to differentiate, OSN pioneer axons infiltrate the
primordial OB [10,11], as do OECs, which wrap OSN
axons [57,62-65]. How might OSNs/OECs influence the
cell-fate specification properties of Neurog1/2 in the OB?
OSNs secrete Fgf8 to noncell-autonomously reduce OB
progenitor cell proliferation [11-16], while OECs pro-
duce an unknown chemoattractant that guides OB neur-
onal migration [66]. One possibility is that the activation
of downstream signaling pathways in the OB triggers a
change in the cell-fate specification properties of
Neurog1 and Neurog2. For instance, modification by
Neurog1/2 by phosphorylation might result in the cap-
acity of these proneural genes to turn on the expression
of genes such as Tcfap2e, which is specifically expressed
in OB lineages, a possibility that will be investigated in
the future.Neurog1/2 control a binary choice between excitatory and
inhibitory lineages in the olfactory bulb
In the region of the dorsal telencephalon that will be-
come the neocortex, Neurog1/2 regulate a binary fate
choice between dorsal, glutamatergic versus ventral,
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Neurog2KI/KI and Neurog1/2−/− embryos, neocortical
progenitors and their neuronal derivatives are misspeci-
fied, acquiring a dorsal LGE-like identity [19]. Notably,
the dorsal LGE is the ventral telencephalic progenitor
zone from which most OB interneurons arise during
embryogenesis, including granule cells and periglomeru-
lar cells [13,35,43,44,67]. Consistent with the expansion
of a dorsal LGE-like progenitor pool in Neurog2KI/KI and
Neurog1/2−/− embryos, several interneuron markers
were ectopically expressed in the mutant OBs/OBLSs.
OB interneuron differentiation is regulated by multiple
transcription factors, including Ascl1 and Dlx1/2, which
control distinct differentiation pathways [6,35,68]. Here
we found that Ascl1 and Dlx1/2 are both upregulated in
the Neurog2KI/KI OB and Neurog1/2−/− OBLS from E13.5
of development, as previously reported in the neocortex
[18]. Additional transcription factors required for the
differentiation of subsets of OB interneurons were also
ectopically expressed in the Neurog2KI/KI OB and Neu-
rog1/2−/− OBLS, including Sp8 [41], Pax6 [44,69] and
Er81 [70]. By monitoring interneuron marker expression
in GFP-labeled OB cells derived from the Neurog2
lineage, we were able to show that the ectopic Sp8-
expressing, Pax6-expressing and Er81-expressing inter-
neurons in Neurog2KI/KI and Neurog1/2−/− OBs were
derived from pallial progenitors that had undergone a
fate switch, as opposed to an increase in the migration
of OB interneurons. Neurog1/2 thus play a similar role
in regulating a binary fate switch between an excitatory
glutamatergic neuronal phenotype versus inhibitory
interneuron phenotype in both the OB (present study)
and neocortex [18,19].
Neurog1 regulates OB tissue morphogenesis, proliferation
and lamination by controlling OSN innervation of the OB
We show here that Neurog1/2−/− embryos have severe
defects in OB morphogenesis, forming an aberrantly
localized OBLS in the ventrolateral brain. Interestingly,
similar OB morphological defects are also observed in
Pax6 mutants [3,60] and Lhx2 mutants [71], cortical se-
lector genes that are required to specify dorsal telence-
phalic regional identities [72,73]. In contrast, the
morphogenetic defects observed in the Neurog1−/− OB
are more modest, with a reduction in OB size and aber-
rant lamination of the GL and MCL. Given that the driv-
ing force for OB morphogenesis is thought to be a
reduction in proliferation in the presumptive OB at the
rostral tip of the telencephalon, which is left behind as
surrounding neocortical territories expand [11,12], we
examined proliferation in Neurog1/2 mutant embryos.
We found that proliferation rates do not decline in the
presumptive OB versus neocortex in either Neurog1−/−
or Neurog1/2−/− embryos, probably accounting at leastin part for the inability of the OB to protrude outwards.
Nevertheless, differences in proliferation alone cannot
explain why the OBLS morphogenesis defects in Neu-
rog1/2−/− embryos are so much more striking than those
observed in Neurog1−/− OBs. We speculate that the
added OB neuronal specification defects observed in
Neurog1/2−/− embryos (present study), Pax6−/− embryos
[3,60] and Lhx2−/− embryos [71], which are not observed
in the Neurog1−/− OB, may alter neuronal migratory
routes, hence influencing the aberrant positioning of the
OBLS.
Several studies have suggested that the normal reduc-
tion in proliferation of presumptive OB versus neocor-
tical progenitors is induced by the innervation of the OB
by OSN axons [11]. The first pioneer OSN axons innerv-
ate the OB at E11, when OB morphogenesis first begins,
but it is not until E13 to E15 that a sizeable number of
OSN axons enter the OB, first innervating the ONL and
later infiltrating the GL, where they make synaptic con-
tacts with mitral cell dendrites [11,64,74-76]. Consistent
with these studies, we found that Neurog1−/− and Neu-
rog1/2−/− OSN axons do not innervate the OB, instead
terminating prematurely in a FCM. The FCM formation
and lack of OB innervation in Neurog1−/− embryos is
also strikingly similar to the phenotypes observed in
Arx, Fezf1 and Dlx5 mutants, which also develop a smal-
ler OB with aberrant MCL and GL lamination [13-16].
However, Dlx5, Arx and Fezf1 are not expressed in pal-
lial lineages – but rather in subpallial and/or OSN
lineages, where they control the differentiation and/or
migration of OB interneurons through cell autonomous
and nonautonomous mechanisms [13-16]. Strikingly, the
abnormal formation of the MCL and GL in Neurog1−/−
OBs more closely resembles phenotypes observed fol-
lowing the mutation of genes that are expressed in OSN
lineages and prevent innervations of the OB, including
Fezf1, Dlx5 and Klf7 [16,77,78].
Why do Neurog1−/− OSNs fail to innervate the OB?
The basal lamina surrounding the brain is remodeled at
E14.5 to allow OSN axon penetration, an event that
depends on canonical Wnt signaling [79] and matrix
metalloproteinases. In Dlx5 mutants, the defects in OSN
penetration of the OB may be related either to defective
differentiation of OSNs, which similar to Neurog1−/−
OSNs also express markers of differentiated neurons, or
in the frontronasal mesenchyme, which also expresses
Dlx5 [13]. In Fezf1 mutants, the removal of this basal
lamina has been shown to rescue the OSN phenotype,
resulting in OSN penetration of the OB. Other possibil-
ities include the loss of a chemoattractant activity in the
Neurog1−/− OB itself. While we did not identify any
defects in the expression of the neurotrophin receptors
or ligands in the OB or OE of Neurog1/2−/−, Neurog1
has been shown to regulate the OB expression of
Figure 10 (See legend on next page.)
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Figure 10 Normal OSN and OEC differentiation in Neurog1−/− and Neurog2−/− mutants, but apoptosis elevated in double mutants. (A)
to (D) Expression of SCG10 in wild-type (A), Neurog1−/− (B), Neurog2−/− (C), and Neurog1/2−/− (D) OBs at embryonic day (E) 18.5. (E) to (P) Co-
labeling with DAPI (blue, E to P) and OMP (green, E to H), NCAM (green, I to L), GFP (green, M to P), p75 (red, I to L), or S100b (red, M to P) in
wild-type (E,I,M), Neurog1−/− (F,J,N), Neurog2−/− (G,K,O), and Neurog1/2−/− (H,L,P) OBs at E18.5. (Q) to (T) Co-labeling with DAPI (blue) and
activated caspase 3 (AC3; red) in wild-type (Q), Neurog1−/− (R), Neurog2−/− (S), and Neurog1/2−/− (T) OBs at E14.5. (U) to (W) Schematic
representation of the three components of the olfactory system (U). The normal process of OSN innervation of the OB, and the subsequent
formation of the glomerular layer by migrating OB interneurons (V) is perturbed in Neurog1/2−/− embryos (W). OB, olfactory bulb; OE, olfactory
epithelium; OEC, olfactory ensheathing cell; OSN, olfactory sensory neuron; PC, piriform cortex. Scale bars: 500 μm (A) to (P), 250 μm (Q) to (T).
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G-protein coupled receptors. Notably, PK2-deficient
mice phenocopy the Neurog1−/− OB defects, at least in
part because PK2 functions as a chemoattractant for OB
interneurons born in the ventral telencephalon [80]. Fu-
ture work will be required to determine whether PK2
also functions as a chemoattractant for OSN axons, and
to determine whether Neurog1 function is required in
the OB and/or OE for OSN innervation of the OB.
Neurog1 is required for olfactory sensory neuron
innervation of the olfactory bulb
Previous analyses of the Neurog1−/− OE revealed that
fewer OSNs express a subset of mature neuronal mar-
kers at early developmental stages (E12.5), including the
pan-neuronal marker SCG10, suggestive of a block in
differentiation [22]. However, these defects are only par-
tial, as other OSN markers, such as Ebf1 and Lhx2, are
expressed at normal levels in E12.5 Neurog1−/− OSNs.
Here we examined the differentiation of Neurog1−/− and
Neurog1/2−/− OSNs at a later developmental stage
(E18.5), revealing only a minor reduction in the expres-
sion of mature OSN markers, including SCG10, GAP43,
OMP and the OR genes L45, M72 and P2. The expres-
sion of mature OSN markers in the Neurog1−/− OE may
be due in part to the maintained expression of Lhx2,
which is required to initiate OE differentiation [61], or
Six1, which functions upstream of Neurog1 to regulate
OSN differentiation [81].
In addition to the ability of the OE to influence OB
development, it has conversely been suggested that the
OB can influence the OE. Indeed, bulbectomy results in
a loss of OSN marker expression and increased apop-
tosis in the OE [59]. In this regard it is interesting that
in Neurog1/2−/− OE there is an increase in apoptosis that
is not observed in the Neurog1−/− OE. At first glance,
this is surprising, as Neurog2 is only expressed in a small
dorsomedial domain of the OE (present study), whereas
Neurog1 expression is widespread [22]. While Neurog2
cannot rescue the OSN innervation defects observed in
Neurog1−/− embryos, we cannot rule out the possibility
that Neurog2 initiates the expression of survival signals
in the OSN, thereby compensating for the loss of Neu-
rog1 in the OE. However, given the limited expressiondomain of Neurog2, we do not believe that this is the
case. Instead we suggest that the Neurog1/2−/− OBLS is
deficient in a trophic signal that is an essential survival
signal for OSNs in the OE. While we investigated
whether the neurotrophins might be contributing to the
death of the OSNs, no defects in Ntrk receptor or ligand
expression in the OE was observed in the Neurog1/2
mutants, suggesting that other factors must be involved.
Conclusions
In this article we find that both Neurog1 and Neurog2
are expressed in OB progenitors, where they function re-
dundantly to specify the identities of glutamatergic OB
neurons, including mitral and juxtaglomerular cells.
Conversely we show that Neurog1 is required to pro-
mote OSN innervation of the OB, and consequently
influences OB proliferation and morphogenesis. We thus
conclude that the proneural genes Neurog1 and Neurog2
coordinately regulate development of the olfactory sys-
tem by regulating proliferation, cell fate specification,
neuronal migration and axonal innervation.
Methods
Animals and genotyping
The generation of Neurog1 and a Neurog2GFP KI null al-
lele was previously described [24,29]. Double heterozy-
gous mice carrying null alleles of Neurog1 and
Neurog2KI were maintained on a CD1 background and
males and females were crossed to generate embryos.
Mating was confirmed via vaginal plugs, with mouse
embryos being staged by considering the plug date as
E0.5. Embryos were genotyped as previously described
[19,24]. All animal procedures were approved by the
University of Calgary Animal Care Committee (Protocol
# AC11-0053) in agreement with the Guidelines of the
Canadian Council of Animal Care (CCAC).
RNA in situ hybridization
Embryonic dissections were performed in PBS. Tissue was
fixed at 4°C in 4% paraformaldehyde/1× PBS overnight,
rinsed in 1× PBS and then cryoprotected in 20% sucrose/
1× PBS at 4°C before embedding in Tissue-Tek optimum
cutting temperature (O.C.T.) compound (VWR Canada,
Mississauga, ON, Canada). Tissue sections (10 μm) were
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ON, Canada) slides using a CM3050-S cryostat (Leica
Microsystems, Richmond Hill, ON, Canada). RNA in situ
hybridization was performed as previously described [82].
The following riboprobes were used: Ascl1 [83], BDNF
(IMAGE:1397218), Dlx1 [84], Emx1 [85], Fgfr1 [86], Gad1
[87], Lhx2 [72], NeuroD1 [88], NeuroD6 [89], Neurog1
(IMAGE:30146192), Neurog2 [17], NGF (IMAGE:
4190781), NT3 (IMAGE: 1177923), Ntrk1 (IMAGE:
421391), Ntrk2 (IMAGE:5707891), Ntrk3 (IMAGE:
40110345), SCG10 [90], Tcfap2e (IMAGE:778986) and
L45, M72 and P2 odorant receptors (gifts from J-F
Cloutier).Immunohistochemistry
Tissue sections were blocked in 10% horse serum/1×
TBST (50 mM Tris–HCl, 150 mM NaCl, pH 7.4, 0.05%
Triton X-100) for 1 hour at 37°C. For BrdU immunola-
beling, the sections were first denatured in 2 N HCl for
30 minutes at 37°C prior to applying the blocking solu-
tion. Sections were incubated with primary antibodies
diluted in 1× TBST overnight at 4°C. Sections were
washed three times in 1× TBST for 10 minutes, then
incubated with secondary antibodies diluted in 1× TBST
for 1 hour at room temperature, before washing the sec-
tions again three times with 1× TBST for 10 minutes.
Next, DAPI (Polysciences Inc., Warrington PA, USA)
diluted in 1× TBST (1/10,000) was applied for 5 minutes.
Finally, the sections were washed three times in 1× TBST,
mounted with Aqua Polymount (Polysciences). The follow-
ing primary antibodies were used: rabbit anti-activated cas-
pase 3 (1/500; Promega, Madison, WI, USA), rat anti-Brdu
(1/500; Roche, Mississauga, ON, Canada), rabbit anti-
calretinin (1/2,000; Swant, Bellinzona, Switzerland), rabbit
anti-Er81 (1/300; Developmental Studies Hybridoma Bank,
Iowa City, IA, USA), rabbit anti-GAP43 (1/750; Millipore
Canada, Etobicoke, ON, Canada), rabbit anti-GFP (1/500;
Invitrogen (Burlington, ON, Canada), mouse anti-GFP
(1/500; Millipore), rat anti-L1 (1/500; Millipore), goat anti-
Neurog1 (1/100; Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA), mouse anti-Neurog2 (1/3; Dr David
Anderson [91]), goat anti-OMP (1/5,000; Wako Chemicals
USA, Richmond, VA, USA), rabbit anti-Pax6 (1/500;
Berkeley Antibody Company (BAbCO, Richmond, CA,
USA), rat anti-PSA-NCAM (1/500; Millipore,), rabbit anti-
S100b (1/500; Dako Canada Inc., Burlington, ON, Canada),
rabbit anti-Slc7a6 (1/600; Synaptic Systems GmbH, Goet-
tingen, Germany), rabbit anti-Slc17a7 (1/750; Synaptic Sys-
tems), goat anti-Sp8 (1/1,000; Santa Cruz), rabbit anti-TH
(1/500; Santa Cruz), rabbit anti-Tbr1 (1/600; AbCam
(Cambridge, MA, USA), rabbit anti-Tbr2 (1/800; AbCam),
rabbit anti-vGlut1 (1/500; Synaptic Systems) and rabbit
anti-vGlut2 (1/500; Synaptic Systems).Histological staining
Whole E18.5 heads were placed in Bouin’s fixative and
processed for paraffin sectioning as previously described
[92]. Sections were deparaffinized in three xylene washes
for 3 minutes each, followed by rehydration in a decreas-
ing ethanol series (2× 100%, 2× 95% and 2× 80%) for 3
minutes each. Slides were then immersed in water for 5
minutes, before staining in hematoxylin for 3 minutes.
The slides were then rinsed in water for 2 minutes, and
stained in eosin for 30 seconds. Slides were then dehy-
drated in 3-minute ethanol washes in an ascending
series (2× 80%, 2× 95% and 2× 100%). Finally, the tissues
were incubated in xylene overnight, and mounted in
Permount SP15-100 Toluene Solution (Fisher Scientific).
Statistical analysis
Composite photomicrographs of the entire OB were
used to count immunoreactive cells from a minimum of
three embryos and three sections per embryo. Graphs
and statistical tests were generated with GraphPad Prism
Software version 5.0 (GraphPad Software Inc., La Jolla,
CA, USA). Error bars represent the standard error of the
mean. Statistical significance was determined using one-
way analysis of variance and a post-hoc Tukey’s test.
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